Judith Feinberg

11.7k total citations · 2 hit papers
169 papers, 8.0k citations indexed

About

Judith Feinberg is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Judith Feinberg has authored 169 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Epidemiology, 92 papers in Infectious Diseases and 42 papers in Virology. Recurrent topics in Judith Feinberg's work include HIV/AIDS Research and Interventions (58 papers), HIV/AIDS drug development and treatment (53 papers) and HIV Research and Treatment (42 papers). Judith Feinberg is often cited by papers focused on HIV/AIDS Research and Interventions (58 papers), HIV/AIDS drug development and treatment (53 papers) and HIV Research and Treatment (42 papers). Judith Feinberg collaborates with scholars based in United States, United Kingdom and Canada. Judith Feinberg's co-authors include Margaret A. Fischl, Joseph J. Eron, Lawrence Deyton, Kathleen Squires, Scott M. Hammer, Judith S. Currier, Louise Pedneault, Lisa M. Demeter, Jon C. Cook and Bach‐Yen Nguyen and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Judith Feinberg

157 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

1997 2.1k citations Kathleen Squires, Judith S. Currier et al. profile →
Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study

2014 350 citations Judith Feinberg et al. profile →

Peers

Countries citing papers authored by Judith Feinberg

Since Specialization

Citations

This map shows the geographic impact of Judith Feinberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Feinberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Feinberg more than expected).

Fields of papers citing papers by Judith Feinberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith Feinberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Feinberg. The network helps show where Judith Feinberg may publish in the future.

Co-authorship network of co-authors of Judith Feinberg

This figure shows the co-authorship network connecting the top 25 collaborators of Judith Feinberg. A scholar is included among the top collaborators of Judith Feinberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith Feinberg. Judith Feinberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Barriers to accessing medications for opioid use disorder among rural individuals 2025 ·International Journal of Drug Policy ·Anna M. Morenz, Robin M. Nance, (unknown), Judith Feinberg, Gordon S. Smith, P. Todd Korthuis, Mai T. Pho, Wiley D. Jenkins, Peter D. Friedmann, Thomas J. Stopka, Laura Fanucchi, William C. Miller, Vivian F. Go, Ryan P. Westergaard, David W. Seal, William A. Zule, Heidi M. Crane, Joseph A. Delaney, Judith I. Tsui	4
2	Interest in Injectable and Oral PrEP for HIV Prevention Among Women and Men Who Inject Drugs 2025 ·Journal of Addiction Medicine ·(unknown), Judith I. Tsui, Moonseong Heo, (unknown), (unknown), Shruti H. Mehta, Paula J. Lum, Lynn E. Taylor, Judith Feinberg, Arthur Y. Kim, Brianna L. Norton, Irene Pericot‐Valverde, Kimberly Page	0
3	HIV Prevention in Syringe Service Programs Since the Start of COVID-19: Where Do We Go From Here? 2025 ·Current HIV/AIDS Reports ·(unknown), Melissa M. Ertl, (unknown), (unknown), Judith Feinberg, (unknown), Susan Tross	1
4	Vertical Transmission of Hepatitis C Virus Among Women With a History of Injection Opioid Use 2024 ·Clinical Infectious Diseases ·John Cafardi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jason T. Blackard, Judith Feinberg	1
5	Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiative 2024 ·Harm Reduction Journal ·Suzan M. Walters, Robin Baker, David Frank, (unknown), Abby E. Rudolph, William A. Zule, Rob J. Fredericksen, Rebecca Bolinski, (unknown), Vivian F. Go, Lawrence J. Ouellet, Mai T. Pho, David W. Seal, Judith Feinberg, Gordon S. Smith, April M. Young, Thomas J. Stopka	3
6	Current Self-reported Pain Before and After Cure of Hepatitis C Among Persons Who Actively Inject Drugs 2024 ·Journal of Addiction Medicine ·Judith I. Tsui, (unknown), (unknown), Moonseong Heo, (unknown), Julia H. Arnsten, Paula J. Lum, Lynn E. Taylor, Shruti H. Mehta, Oluwaseun Falade‐Nwulia, Judith Feinberg, Arthur Y Kim, Brianna L. Norton, (unknown), Alain H. Litwin	0
7	Behavioral and Health Outcome Differences by Heroin or Methamphetamine Preference Among People in Rural US Communities Who Use Both Substances 2024 ·PubMed ·(unknown), Bridget M. Whitney, Wiley D. Jenkins, Thomas J. Stopka, P. Todd Korthuis, Lydia N. Drumright, (unknown), Peter D. Friedmann, Mai T. Pho, April M. Young, Ryan P. Westergaard, David W. Seal, Vivian F. Go, William C. Miller, William A. Zule, Judith Feinberg, Hannah L. F. Cooper, Judith I. Tsui, Heidi M. Crane, Joseph A. Delaney	0
8	High suicidality predicts overdose events among people with substance use disorder: A latent class analysis 2023 ·Frontiers in Public Health ·Renae D. Schmidt, Viviana E. Horigian, Dikla Shmueli‐Blumberg, Kathryn Hefner, Judith Feinberg, (unknown), Daniel J. Feaster, Rui Duan, (unknown), (unknown), (unknown), Rodrigo Marín-Navarrete, Susan Tross	0
9	Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs: The HERO study 2023 ·International Journal of Drug Policy ·(unknown), Irene Pericot‐Valverde, Julia H. Arnsten, Paula J. Lum, Lynn E. Taylor, Shruti H. Mehta, Judith I. Tsui, Judith Feinberg, Arthur Y. Kim, Brianna L. Norton, Kimberly Page, Cristina Murray‐Krezan, Jessica Anderson, Phillip Moschella, Moonseong Heo, Alain H. Litwin	3
10	Shame and stigma in association with the HCV cascade to cure among people who inject drugs 2023 ·Drug and Alcohol Dependence ·Abigail Batchelder, Moonseong Heo, (unknown), Matthew C. Sullivan, Paula J. Lum, (unknown), Lynn E. Taylor, Shruti H. Mehta, Arthur Y. Kim, Brianna L. Norton, Judith I. Tsui, Judith Feinberg, Kimberly Page, Alain H. Litwin	6
11	Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities 2023 ·International Journal of Drug Policy ·(unknown), William C. Miller, David Kline, Bridget M. Whitney, April M. Young, P. Todd Korthuis, Thomas J. Stopka, Judith Feinberg, William A. Zule, Mai T. Pho, Peter D. Friedmann, Ryan P. Westergaard, (unknown), (unknown), (unknown), Vivian F. Go, Kathryn E. Lancaster	4
12	A Video-Observed Treatment Strategy to Improve Adherence to Treatment Among Persons Who Inject Drugs Infected With Hepatitis C Virus: Qualitative Study of Stakeholder Perceptions and Experiences 2023 ·Journal of Medical Internet Research ·Alison Karasz, (unknown), Julia H. Arnsten, Judith Feinberg, Arthur Y. Kim, Paula J. Lum, M. Diane McKee, Shruti H. Mehta, Paul Meißner, Brianna L. Norton, Kimberly Page, Irene Pericot‐Valverde, (unknown), Ellen Stein, Lynn E. Taylor, Judith I. Tsui, Katherine Wagner, Alain H. Litwin	1
13	Supportive environments during the substance use disorder epidemic in the rural United States: Provider support for interventions and expectations of interactions with providers 2022 ·Social Science & Medicine ·Thomas C. O’Brien, Judith Feinberg, Robert Gross, Dolores Albarracín	1
14	Health Needs of HIV-Infected Women in the United States: Insights from The Women Living Positive Survey 2011 ·AIDS Patient Care and STDs ·Kathleen Squires, Sally Hodder, Judith Feinberg, (unknown), (unknown), Stephen P. Storfer, Judith A. Aberg	56
15	Sex-Based Outcomes of Darunavir–Ritonavir Therapy: The GRACE (Gender, Race, and Clinical Experience) Study 2010 ·Annals of Internal Medicine ·Judith S. Currier, (unknown), Debbie Hagins, Carmen Zorrilla, Judith Feinberg, Robert J. Ryan, (unknown), Alan M. Tennenberg, Joseph Mrus, Kathleen Squires	6
16	Sex-Based Outcomes of Darunavir-Ritonavir Therapy 2010 ·Annals of Internal Medicine ·Judith S. Currier, (unknown), Debbie Hagins, Carmen Zorrilla, Judith Feinberg, Robert J. Ryan, (unknown), Alan M. Tennenberg, Joseph Mrus, Kathleen Squires	2
17	Drug evaluation: bevirimat--HIV Gag protein and viral maturation inhibitor. 2006 ·PubMed ·Zelalem Temesgen, Judith Feinberg	8
18	Suboptimal Response to Once-Daily Abacavir + 3TC + Tenofovir 2003 ·Journal watch ·Judith Feinberg	1
19	Intravitreal ganciclovir salvage therapy for cytomegalovirus retinitis in AIDS: AIDS clinical trials group protocol 085 1996 ·International Journal of Infectious Diseases ·Bruce Polsky, Shelley Hurwitz, Elaine L. Chuang, Richard A. Wolitz, Herbert L. Cantrill, (unknown), Michael Sands, Maureen Power, Susan Owens, Roger B. Davis, Judith Feinberg	1
20	Determinants of accrual of women to a large, multicenter clinical trials program of human immunodeficiency virus infection. The AIDS Clinical Trials Group. 1993 ·PubMed ·Deborah Cotton, Daniel Finkelstein, Weili He, Judith Feinberg	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact